PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
Recruiting · NCT05098665 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies | Recruiting | Not applicable | 2026-06-16 | NCT05098665 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Amyloidosis Centre | 1 |
| Richmond Pharmacology Limited | 3 |
| Richmond Research Institute | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Richmond Research Institute | London | United Kingdom | 1 |